A curcumin analog, ASC-J9, tested in cells and in a mouse model of SBMA, demonstrated beneficial effects on mutated AR aggregates, motor impairments, muscular atrophy, and VEGF expression [214]. This evidence concerns the gene VEGFA and Kennedy disease.